Live feed
Filing
SC 13G/A
SC 13G/A0000930413-18-000506·SEELOS THERAPEUTICS, INC.
Schedule 13G ownership disclosure
APRICUS BIOSCIENCES INC
Security class unavailable · CUSIP: 03832V307
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 656,918
- Percent of class
- 4.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000930413-18-000506
- Form type
- SC 13G/A
- Filer
- SEELOS THERAPEUTICS, INC.
- CIK
- CIK 1017491
- Filed
- Feb 14, 2018
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership